Your browser doesn't support javascript.
loading
Targeting EZH2 for the treatment of hepatosplenic T-cell lymphoma.
Pikman, Yana; Conway, Amy Saur; Robichaud, Amanda L; Kitara, Samuel; Church, Alanna J; Kennedy, Alyssa L; Silverman, Lewis B; Billett, Amy L; Weinstock, David M; Harris, Marian H; Stegmaier, Kimberly.
Afiliação
  • Pikman Y; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Conway AS; Division of Hematology/Oncology and.
  • Robichaud AL; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Kitara S; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Church AJ; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Kennedy AL; Department of Pathology, Boston Children's Hospital, Boston, MA.
  • Silverman LB; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Billett AL; Division of Hematology/Oncology and.
  • Weinstock DM; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Harris MH; Division of Hematology/Oncology and.
  • Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA.
Blood Adv ; 4(7): 1265-1269, 2020 04 14.
Article em En | MEDLINE | ID: mdl-32232478
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Células T Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Células T Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2020 Tipo de documento: Article